TY - JOUR T1 - â–¼Paclitaxel for ovarian cancer JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 41 LP - 42 DO - 10.1136/dtb.1994.32641 VL - 32 IS - 6 A2 - , Y1 - 1994/06/01 UR - http://dtb.bmj.com/content/32/6/41.abstract N2 - Relevant BNF section: 8.1.5Paclitaxel (Taxol - Bristol-Myers Squibb) is the first of a new group of cytotoxic drugs, the taxanes. It is licensed for the treatment of patients with metastatic ovarian carcinoma "where standard, platinum-containing, therapy has failed". What is its place in treatment? ER -